NIVOLUMAB-INDUCED MYASTHENIA GRAVIS WITH MYOCARDITIS AND MYOSITIS

被引：0
|
作者：
Tamkus, Greta
Boucekkine, Houda
Seibert, Katherine
Eng, Kevin
Betancourt, Jaime
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.2779
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：4268A / 4269A
页数：2
相关论文
共 50 条
  • [31] Clinical characteristics, diagnosis and management of nivolumab-induced myocarditis
    Meng-Ting Li
    Yang He
    Si-Yong Huang
    Xiao Hu
    Ji-Sheng Chen
    Investigational New Drugs, 2024, 42 : 116 - 126
  • [32] Nivolumab/pegaldesleukinDe novo myasthenia gravis and myositis: 2 case reports
    Reactions Weekly, 2020, 1808 (1) : 231 - 231
  • [33] PEMBROLIZUMAB-INDUCED TRIPLE-M (MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS) SYNDROME
    Onkaramurthy, Neema Jayachamarajapura
    Kumar, Sany
    Pastores, Stephen
    CRITICAL CARE MEDICINE, 2024, 52
  • [34] Immunotherapy-Induced Overlap Syndrome: Myositis, Myasthenia Gravis, and Myocarditis-A Case Series
    Aggarwal, Nikhil
    Bianchini, Diletta
    Parkar, Rosemeen
    Turner, Jennifer
    CASE REPORTS IN MEDICINE, 2024, 2024
  • [35] Fatal triad of checkpoint inhibitors: Pembrolizumab induced myasthenia gravis with myositis and myocarditis in a patient with thymoma
    Seker, Demet
    Yildirim, Ahmet
    NEUROLOGY ASIA, 2023, 28 (02) : 439 - 443
  • [36] Pembrolizumab-induced Myasthenia Gravis and Myocarditis
    Won, Jisun
    Zhao, Edward
    States, Melissa
    Brown, Rachel
    El-habr, Abdallah
    Damsker, Jason
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2024, 14 (03):
  • [37] TRIPLE-M (MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS) SYNDROME IN A PATIENT RECEIVING NIVOLUMAB: A CARDIO-ONCOLOGIC EMERGENCY
    Golec, Sophia
    Mitrani, Lindsey
    Yoon, Joseph
    Dangayach, Neha
    Sahni, Gagan D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3459 - 3459
  • [38] Myocarditis in myasthenia gravis
    Finsterer, Josef
    Stoellberger, Claudia
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 209 : 342 - 343
  • [39] ACUTE RIGHT HEART FAILURE SECONDARY TO NIVOLUMAB-INDUCED MYOCARDITIS
    Alghothani, Y.
    Alghothani, L.
    Amin, E.
    CHEST, 2019, 155 (04) : 90A - 90A
  • [40] 3M syndrome (myasthenia, myositis, myocarditis) related to nivolumab treatment
    Rouby, F.
    Polard, E.
    Pietri, T.
    Laugier, D.
    Micallef, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 13 - 14
12345